• Accueil >
  • Publications >
  • The iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancers

The iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancers

1 sept. 2018The Journal of Pathology

DOI : 10.1002/path.5104

Auteurs

Sandrine Tury, Franck Assayag, Florian Bonin, Sophie Chateau-Joubert, Jean-Luc Servely, Sophie Vacher, Véronique Becette, Martial Caly, Audrey Rapinat, David Gentien, Pierre de la Grange, Anne Schnitzler, François Lallemand, Elisabetta Marangoni, Ivan Bièche, Céline Callens